Differential miRNA Expression IDs Urothelial Cancer Grade

This article originally appeared here.
Share this content:
Differential miRNA Expression IDs Urothelial Cancer Grade
Differential miRNA Expression IDs Urothelial Cancer Grade

(HealthDay News) -- Four microRNAs (miRNAs) are differentially expressed in low-grade noninvasive (pTa) and high-grade invasive (pT2-3) urothelial carcinoma, and show potential as diagnostic or prognostic markers, according to a study published in the November issue of The Journal of Urology.

Nelson Dip, from the University of São Paulo Medical School in Brazil, and colleagues examined expression of 14 miRNAs in urothelial carcinoma. Quantitative reverse transcriptase-polymerase chain reaction was performed on surgical specimens from 30 patients with low-grade pTa and 30 with high-grade pT2-3 urothelial carcinoma, and expression was compared with normal bladder tissue from five patients who underwent surgery for benign prostatic hyperplasia.

The researchers found that, in 100 percent of low-grade pTa specimens, miR-100 was significantly underexpressed, while miR-10a was significantly overexpressed in 73.3 percent. In high-grade pT2-3 disease, miR-21 and miR-205 were significantly overexpressed. Expression of other miRNAs was similar to that of normal bladder tissue or was underexpressed in each tumor group. For patients with low-grade pTa urothelial carcinoma, miR-21 over expression correlated with shorter disease-free survival. For patients with high-grade pT2-3 urothelial carcinoma, increased miR-10a levels correlated with shorter disease-free and disease-specific survival.

"Low-grade pTa and high-grade pT2-3 urothelial carcinomas show differences with respect to miRNA expression that could be incorporated into the well-known carcinogenic pathway," the authors write. "Aberrant miRNA levels could be used as new biomarkers to better treat patients with bladder cancer or those susceptible to the neoplasm."


Full Text

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs